Chronic Disease Curveball · Advanced · Older adults
End of Life Care: Pain Management
Practise this SCA case with a voice-based AI patient that responds in real time — just like the real exam.
Clinical Scenario
Margaret Davies, 68, calls about her husband Brian, 71, who has metastatic pancreatic cancer and is being cared for at home with palliative intent. Brian's pain has escalated over the past week despite regular oral morphine 20mg four-hourly. He is now struggling to swallow tablets and had a distressing episode of breakthrough pain overnight that lasted 2 hours. Margaret is exhausted, frightened, and feels she is 'failing him.' She is reluctant to increase the morphine because she believes it will 'hasten his death' and a neighbour told her morphine causes addiction. She wants reassurance and guidance.
What This Case Tests
Addressing morphine myths sensitively and accurately; converting oral morphine to subcutaneous route when swallowing becomes difficult; calculating breakthrough doses correctly; explaining anticipatory prescribing and the role of the syringe driver; supporting the carer's emotional and practical needs; coordinating with the district nursing team and palliative care services
Common Mistakes Trainees Make
The three most common mistakes are: failing to address Margaret's fear that morphine will hasten Brian's death — this myth is one of the biggest barriers to adequate pain control in palliative care, and if you do not tackle it directly, she will resist dose increases; not recognising that the swallowing difficulty requires a route change to subcutaneous delivery, and instead trying to optimise oral medication; and focusing entirely on Brian's clinical management without supporting Margaret, who is an exhausted carer at breaking point and needs help in her own right.
The Consultation Challenge
Margaret is frightened, exhausted, and carrying an enormous burden. She is watching her husband die and feels responsible for his pain management. Before you address any clinical issues, you need to address her.
Start with acknowledgement: 'Margaret, first of all, I want to say that what you are doing for Brian is extraordinary. Caring for someone at home through this stage takes enormous strength and love, and you are not failing him — you are doing everything you can.'
Address the morphine fears directly and with authority. This is the most important part of the consultation: 'I want to talk about your worries about the morphine, because I think clearing this up will make a big difference. Morphine given for pain, at the right dose, does not hasten death — the research is very clear on this. When we increase the dose, we are matching the medication to the pain, not suppressing Brian's breathing. The pain itself is more harmful than the morphine.' Address the addiction concern: 'When someone is in pain from cancer, their body uses the morphine for pain relief. This is completely different from addiction. Brian will not become addicted — he is using it for what it was designed for.'
Address the swallowing difficulty. Brian can no longer reliably take oral tablets, which means a route change is needed. Explain the syringe driver: 'A syringe driver is a small pump that sits under the skin and delivers medication continuously over 24 hours. It means Brian gets a constant steady level of pain relief without needing to swallow anything. The district nurses will set it up and check it regularly.' This also provides breakthrough pain management.
Calculate the dose conversion: current oral morphine 20mg four-hourly equals 120mg oral morphine daily. The subcutaneous equivalent is one-third to one-half of the oral dose, so approximately 40-60mg subcutaneous morphine over 24 hours via syringe driver. Breakthrough doses should be one-sixth of the 24-hour dose — approximately 7-10mg subcutaneous as needed.
Discuss anticipatory medications. Explain that you will prescribe medications to have in the house ready for common end-of-life symptoms: morphine for pain and breathlessness, midazolam for agitation or anxiety, levomepromazine for nausea, and hyoscine butylbromide for respiratory secretions. Having these ready means the district nurse can give them promptly without waiting for a prescription.
Support Margaret practically: arrange daily district nurse visits, ensure the palliative care team is involved, offer night sitting services if available, and ask about her own health — is she eating, sleeping, does she have anyone supporting her? Offer a follow-up call tomorrow.
Time check: Minutes 1-3 on supporting Margaret and acknowledging her burden. Minutes 3-6 on addressing morphine myths clearly. Minutes 6-9 on syringe driver explanation, dose conversion, and anticipatory prescribing. Final 3 minutes on practical carer support and follow-up.
How Examiners Mark This Case
Data Gathering and Diagnosis: Examiners assess whether you explore the current pain picture — the dose, frequency, effectiveness, and the breakthrough episode — and identify the swallowing difficulty as a trigger for route change. They look for assessment of Margaret's coping, emotional state, and support needs. Asking about other symptoms (nausea, breathlessness, agitation) demonstrates anticipatory thinking.
Clinical Management and Medical Complexity: Examiners evaluate whether you convert the oral morphine to subcutaneous delivery correctly, calculate breakthrough doses appropriately, and prescribe anticipatory medications for common end-of-life symptoms. Knowing the syringe driver setup process, coordinating with district nursing, and arranging palliative care team input demonstrate system knowledge. The dose calculation is a key clinical competence — getting it wrong could result in under- or over-dosing.
Relating to Others: This domain is paramount. Examiners look for genuine warmth toward Margaret as an exhausted carer, direct and confident addressing of morphine myths (not hedging or being uncertain), and acknowledgement that caring for a dying spouse at home is emotionally and physically devastating. The patient should leave the call feeling reassured about the morphine, confident about the plan, and supported as a person — not just given a prescription change.
Example Opening
Strong opening: "Hello Margaret, thank you for calling. Before we talk about Brian's medications, how are you doing? I know this is an incredibly difficult time."
When addressing morphine fears: "Margaret, I want to be really clear about this because it matters. Morphine given for pain does not hasten death — we know this from decades of research. When I increase the dose, I am matching the medication to Brian's pain. The pain is the enemy here, not the morphine. And I promise you, Brian will not become addicted — his body is using it exactly as it should."
Avoid: "We need to increase the morphine" as an opening move — this will trigger Margaret's fears immediately. Address her emotions and the morphine myths before discussing dose changes.
How This Appears in the SCA
End of life pain management tests your ability to address opioid myths, manage a route conversion when oral medication fails, and support an exhausted carer. Examiners value candidates who combine clinical competence with genuine compassion and who address the carer as a patient in their own right.
Key Statistic
Research consistently demonstrates that appropriate use of opioids for pain in palliative care does not hasten death. A landmark study in the BMJ showed no difference in survival between patients receiving morphine for pain relief and those who did not.
Relevant Guidelines
- NICE NG31: Care of dying adults in the last days of life
- NICE CG140: Palliative care — opioids in palliative care
- NICE QS13: End of life care for adults
- Palliative Care Formulary guidance on syringe driver prescribing.
Frequently Asked Questions
Does morphine hasten death in palliative care?
No. Multiple studies demonstrate that appropriate opioid use for pain in palliative care does not hasten death. The doctrine of double effect recognises that the primary intention of prescribing morphine is pain relief, and that any potential side effect on respiratory function is outweighed by the benefit of comfort. In practice, doses titrated to pain rarely cause clinically significant respiratory depression because the pain itself is a respiratory stimulant. Addressing this myth directly and with confidence is one of the most important communication skills in palliative care.
How do I convert oral morphine to a subcutaneous syringe driver?
Calculate the total 24-hour oral morphine dose (for Brian: 20mg six times daily equals 120mg). The subcutaneous to oral morphine ratio is approximately 1:2 to 1:3 — so divide the oral dose by 2-3 to get the subcutaneous 24-hour dose. For Brian: 120mg divided by 2-3 gives approximately 40-60mg subcutaneous morphine over 24 hours. Start at the lower end and titrate. Breakthrough doses should be one-sixth of the 24-hour subcutaneous dose, given as a subcutaneous bolus injection as needed. Document the calculation clearly.
What anticipatory medications should I prescribe for end of life care at home?
The standard anticipatory medication kit includes: morphine sulphate injection (for pain and breathlessness), midazolam injection (for agitation, anxiety, and seizures), levomepromazine injection (for nausea and vomiting), and hyoscine butylbromide injection (for respiratory secretions). These are prescribed to have in the home so that district nurses can administer them promptly when symptoms arise without waiting for a GP visit or prescription. Ensure clear written instructions accompany the medications specifying indications, doses, and frequency for each.
How do I support an exhausted carer during end of life care?
Acknowledge the burden directly: 'What you are doing is extraordinary, and it is also exhausting.' Ask about their own basic needs: are they eating, sleeping, getting any time away? Arrange practical support: daily district nurse visits, palliative care team involvement, night sitting services where available, and Marie Curie or Hospice at Home if accessible locally. Offer a carer's assessment through social services. Signpost to carers' support groups and bereavement counselling for anticipatory grief. Schedule regular contact so the carer does not feel alone in the process.
When should I involve the specialist palliative care team?
Involve specialist palliative care when: pain or other symptoms are difficult to control with standard first-line approaches, there are complex symptom interactions (such as pain with delirium or breathlessness with anxiety), the carer is struggling and needs additional support, there are ethical or communication challenges (such as family disagreement about treatment goals), or the patient's condition is deteriorating rapidly and the care plan needs specialist review. In Brian's case, the uncontrolled pain and route conversion would be an appropriate trigger for specialist palliative care input to support primary care management.